In addition, our more recent data have shown that LY294002, a specific PI3K inhibitor, significantly reduced the effect of HAb18G/CD147 on cell adhesion and metastatic invasion (p < 0.01) of human hepatoma cells [5]. This evidence concerns the gene BSG and hepatocellular carcinoma.